Literature DB >> 25247664

Neuropsychiatric symptoms in people screened positive for dementia in primary care.

Stefan J Teipel1, Jochen René Thyrian2, Johannes Hertel2, Tilly Eichler2, Diana Wucherer2, Bernhard Michalowsky2, Ingo Kilimann1, Wolfgang Hoffmann2.   

Abstract

BACKGROUND: Neuropsychiatric symptoms are major determinants for caregiver distress and institutionalization in dementia. Little is known about the prevalence of neuropsychiatric symptoms and their association with use of medication, caregiver distress, and resource utilization in primary care.
METHODS: We assessed frequency of neuropsychiatric symptoms in a sample retrieved from a primary care intervention study. Patients were screened for dementia by their primary care physicians. A study nurse assessed neuropsychiatric symptoms in 176 patients using the neuropsychiatric inventory (NPI) through face-to-face interviews by proxy during home visits. In addition, data on global cognition (MMSE), quality of life (QoL-AD), resource utilization in dementia (RUD), caregiver distress (BIS), and use of psychotropic medication in patients were obtained. We used linear mixed effect models taking into account the clustering of patients within general physician practices.
RESULTS: Clinically relevant neuropsychiatric symptoms (NPI score ≥ 4) occurred in about 53% of the patients. Higher NPI scores were significantly associated with more severe cognitive impairment, higher caregiver distress, and higher utilization of caregiver resources by patients but not with a formal diagnosis of dementia from the primary care physician. Use of antipsychotics was associated with higher NPI scores, particularly in non-psychotic domains.
CONCLUSIONS: Neuropsychiatric symptoms in a primary care cohort screened positive for dementia were associated with resource utilization and distress of caregivers. In contrast to guideline recommendations, the use of antipsychotics was associated with non-psychotic domains of behavioral symptoms. These findings underscore the relevance of neuropsychiatric symptoms for the design of future interventions in primary care.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25247664     DOI: 10.1017/S1041610214001987

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  4 in total

1.  Multidimensional assessment of challenging behaviors in advanced stages of dementia in nursing homes-The insideDEM framework.

Authors:  Stefan Teipel; Christina Heine; Albert Hein; Frank Krüger; Andreas Kutschke; Sven Kernebeck; Margareta Halek; Sebastian Bader; Thomas Kirste
Journal:  Alzheimers Dement (Amst)       Date:  2017-04-04

2.  Association Between Amygdala Volume and Trajectories of Neuropsychiatric Symptoms in Alzheimer's Disease and Dementia With Lewy Bodies.

Authors:  Alberto Jaramillo-Jimenez; Lasse M Giil; Diego A Tovar-Rios; Miguel Germán Borda; Daniel Ferreira; Kolbjørn Brønnick; Ketil Oppedal; Dag Aarsland
Journal:  Front Neurol       Date:  2021-07-07       Impact factor: 4.003

3.  The consequences of COVID-19 lockdown for formal and informal resource utilization among home-dwelling people with dementia: results from the prospective PAN.DEM study.

Authors:  Maarja Vislapuu; Renira C Angeles; Line I Berge; Egil Kjerstad; Marie H Gedde; Bettina S Husebo
Journal:  BMC Health Serv Res       Date:  2021-09-22       Impact factor: 2.655

4.  Improving competencies in evidence-based dementia care: Results from a pilot study on a novel inter-professional training course (the KOMPIDEM project).

Authors:  Katrin Balzer; Rhian Schröder; Anne Junghans; Ute Stahl; Jens-Martin Träder; Sascha Köpke
Journal:  GMS J Med Educ       Date:  2016-04-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.